Browse drugs

…and poor prognosis. Adding immune checkpoint inhibitors such as pembrolizumab to neoadjuvant chemotherapy has improved pathological response …

…gical therapy (21%), and other (9%). Most implicated drugs were nivolumab, ipilimumab, carboplatin, paclitaxel, oxaliplatin, and pembroli…

…and sarcoma (0.9%). The most frequently desensitised drugs were paclitaxel (45.4%), oxaliplatin (24.5%), carboplatin (14.1%), docetaxel (9…

…ycle 2 of standard chemotherapy with vincristine, etoposide and carboplatin, his mother had a viral prodrome with myalgia, coryza and sever…

…dvanced small cell lung carcinoma was treated with carboplatin, etoposide and atezolizumab. After two well-tolerated cycles, he developed…

…zinamide and ethambutol, followed by 4-month continuation phase isoniazid, rifampicin and ethambutol) for 6 months. After 3 months, the r…

…patient in sitravatinib+tislelizumab arm; 13 (6.8%) patients in docetaxel arm) (figure 1). One patient randomised to sitravatinib+tisleli…

…noma and sinonasal undifferentiated carcinoma. IA chemotherapy (cisplatin or carboplatin) was administered via selective catheterization …

…agents showed the highest reporting disproportionality, notably dobutamine (reporting OR (ROR) (95% CI) 283.83 (226.55 to 355.60)) and nor…

…s with a history of breast cancer, undergoing chemotherapy with carboplatin and paclitaxel, is referred to the cardio-oncology clinic due t…

…ing to progressive disease (figure 3), palliative chemotherapy (paclitaxel+carboplatin) was administered. Patient expired within 20 days.…

…ounded 60 bags of 19 different drugs, including 5-fluorouracil, bevacizumab, carboplatin, cisplatin, cyclophosphamide, docetaxel, doxorubic…